AstraZeneca to disclose compensation to U.S. doctors
AstraZeneca has announced that it plans to divulge compensation to healthcare professionals who speak on behalf of its company and products in the U.S. starting in 2010.
The London-based AstraZeneca said its U.S. subsidiary in Wilmington, Del., will report compensation to healthcare professionals biannually beginning in 2010, with the first report being posted to www.astrazeneca-us.com in August 2010 for the first six months of 2010. The report will disclose compensation to all practicing healthcare professionals speaking on behalf of the pharmaceutical company.
"AstraZeneca believes it is important to be open about how we conduct our business and how we help people through our medicines and programs," said Rich Fante, U.S. president of AstraZeneca Pharmaceuticals. "In particular, we want the public to better understand how we partner with healthcare professionals to benefit patients."
The London-based AstraZeneca said its U.S. subsidiary in Wilmington, Del., will report compensation to healthcare professionals biannually beginning in 2010, with the first report being posted to www.astrazeneca-us.com in August 2010 for the first six months of 2010. The report will disclose compensation to all practicing healthcare professionals speaking on behalf of the pharmaceutical company.
"AstraZeneca believes it is important to be open about how we conduct our business and how we help people through our medicines and programs," said Rich Fante, U.S. president of AstraZeneca Pharmaceuticals. "In particular, we want the public to better understand how we partner with healthcare professionals to benefit patients."